Roche deploys 3,500 NVIDIA Blackwell GPUs to embed AI across drug discovery and manufacturing
Microsoft trains AI model to convert standard pathology slides into protein maps
Google unveils new Gemini and Nano Banana model updates
Lilly inaugurates LillyPod AI supercomputer to accelerate drug discovery in Indianapolis
NVIDIA survey finds healthcare AI moving from pilots to production with measurable returns
Gilead pays $7.8bn to take full control of a CAR T therapy that could win FDA approval by year-end
Injecting mitochondria from the young into the old
Hims & Hers to buy Eucalyptus for $1.15 billion
Nvidia hosts first AI Day in Brazil as country prepares $4bn push into artificial intelligence
A week in biotech: Four IPOs launch in a single week as Eli Lilly breaks the trillion-dollar barrier
Novo Nordisk's terrible week reveals the brutal economics of the obesity drug gold rush
BrainChild project builds precision cancer treatment platform for children in Sweden
Pfizer’s new weight-loss drug may offer monthly alternative to Wegovy and Mounjaro
Helus Pharma looks to lead a new approach to treating depression
First human trial of cellular reprogramming approved in bid to treat blindness
Nvidia signals record OpenAI investment while distancing itself from $100bn figure
Eli Lilly to build $3.5bn weight-loss drug facility in Pennsylvania
Hims & Hers to air national Big Game ad highlighting healthcare access gap
MoltBot Explained: The viral AI agent formerly ClawdBot
HBO Max unveils February slate of originals, films and live sports
10X Health and Verséa unveil mitochondrial test developed from NASA research
Google.org awards $20m to AI-led science projects tackling health, energy and biodiversity
Biology’s new supply chains: Why the future of biotech may be manufacturing, not discovery
The end of antibiotics, again: phage therapy, bacteriocins, and precision antimicrobials
The immune system’s new teachers: Personalised cancer vaccines and the logistics of made-to-order medicine
Batteries, not brains: Bioelectricity and the new map of how bodies heal
CRISPR’s next act: Editors that rewrite single letters without cutting the DNA
The cell’s postal service: How extracellular vesicles could become the next drug delivery revolution
Living medicines, strange ethics: the rise of engineered microbes that treat disease from the inside
Organoids on a chip: Miniature human tissues that are changing how drugs are tested
The quiet revolution in protein design: Enzymes and binders made by algorithms, built in yeast
New antibiotics explained: Phages, bacteriocins and AI, and why none is a silver bullet
Biofoundries explained: Inside the robot labs, engineering biology at industrial scale
CRISPR delivery explained: Why editing DNA is easier than getting the editor to the right cells
Digital twins in medicine and engineering: How to tell a useful tool from an expensive mirage
Lab-on-a-chip explained: Tiny microfluidic devices that could shrink the laboratory
Biological age tests explained: What they measure, what they miss, and how to read the results
NVIDIA expands BioNeMo platform as pharma groups commit up to $1bn to AI-driven drug discovery
Multiply Labs uses robotics and NVIDIA simulation to scale cell therapy manufacturing
Chai Discovery partners with Eli Lilly to accelerate biologics design with AI
Bayer partners with Cradle to deploy AI platform across antibody research
Novo Nordisk launches Wegovy pill as knownwell joins NovoCare network
Longevity boom reshapes investment outlook as ageing populations stay healthier for longer
Biobeat Technologies raises $50 million to accelerate US rollout of cuff-less blood pressure monitor
Microsoft researcher says AI is learning the language of biology
Palantir Beats The Street As It Upgrades Its Outlook
Lilly’s AI Factory Could Redefine How We Make Medicine
